🇺🇸 FDA

Drug profile · INN

cefadroxil/cefadroxil hemihydrate

DURICEF

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

cefadroxil/cefadroxil hemihydrate (DURICEF) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN cefadroxil/cefadroxil hemihydrate
Brand DURICEF
Route ORAL
Formulation FOR SUSPENSION

Frequently asked questions

What is cefadroxil/cefadroxil hemihydrate?

cefadroxil/cefadroxil hemihydrate (DURICEF) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for cefadroxil/cefadroxil hemihydrate?

DURICEF is a marketed brand name for cefadroxil/cefadroxil hemihydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of cefadroxil/cefadroxil hemihydrate?

cefadroxil/cefadroxil hemihydrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.